Silencing METTL3 Stabilizes Atherosclerotic Plaques by Regulating the Phenotypic Transformation of Vascular Smooth Muscle Cells via the miR-375-3p/PDK1 Axis-Reference-Cited by-同舟云学术

Silencing METTL3 Stabilizes Atherosclerotic Plaques by Regulating the Phenotypic Transformation of Vascular Smooth Muscle Cells via the miR-375-3p/PDK1 Axis

Published:2022-06-15 Issue:3 Volume:37 Page:471-486
ISSN:0920-3206
Container-title:Cardiovascular Drugs and Therapy
language:en
Short-container-title:Cardiovasc Drugs Ther

Author:

Chen Jingquan,Lai Kun,Yong Xi,Yin Hongshun,Chen Zhilong,Wang Haifei,Chen Kai,Zheng Jianghua^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Cardiology and Cardiovascular Medicine,Pharmacology,General Medicine

Link

https://link.springer.com/content/pdf/10.1007/s10557-022-07348-6.pdf

Reference58 articles.

1. Chen L, Zheng J, Xue Q, Zhao Y. YKL-40 promotes the progress of atherosclerosis independent of lipid metabolism in apolipoprotein E(-/-) mice fed a high-fat diet. Heart Vessels. 2019;34:1874–81.

2. Souilhol C, Harmsen MC, Evans PC, Krenning G. Endothelial-mesenchymal transition in atherosclerosis. Cardiovasc Res. 2018;114:565–77.

3. Mao Y, Liu XQ, Song Y, et al. Fibroblast growth factor-2/platelet-derived growth factor enhances atherosclerotic plaque stability. J Cell Mol Med. 2020;24:1128–40.

4. Pan J, Cai Y, Liu M, Li Z. Role of vascular smooth muscle cell phenotypic switching in plaque progression: a hybrid modeling study. J Theor Biol. 2021;526:110794.

5. Wang X, Li H, Zhang Y, et al. Suppression of miR-4463 promotes phenotypic switching in VSMCs treated with Ox-LDL. Cell Tissue Res. 2021;383:1155–65.

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Oral Nanoformulations in Cardiovascular Medicine: Advances in Atherosclerosis Treatment;Pharmaceuticals;2024-07-10

2. N6-methyladenosine-driven miR-143/145-KLF4 circuit orchestrates the phenotypic switch of pulmonary artery smooth muscle cells;Cellular and Molecular Life Sciences;2024-06-12

3. Elucidating VSMC phenotypic transition mechanisms to bridge insights into cardiovascular disease implications;Frontiers in Cardiovascular Medicine;2024-05-13

4. RNA modifications in cellular metabolism: implications for metabolism-targeted therapy and immunotherapy;Signal Transduction and Targeted Therapy;2024-03-27

5. PCSK9i promoting the transformation of AS plaques into a stable plaque by targeting the miR-186-5p/Wipf2 and miR-375-3p/Pdk1/Yap1 in ApoE−/− mice;Frontiers in Medicine;2024-02-26